Literature DB >> 35732695

Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological properties.

Julian Triebelhorn1, Iseline Cardon1, Kerstin Kuffner1, Stefanie Bader1, Tatjana Jahner1, Katrin Meindl1, Tanja Rothhammer-Hampl2, Markus J Riemenschneider2, Konstantin Drexler3, Mark Berneburg3, Caroline Nothdurfter1, André Manook1, Christoph Brochhausen4,5, Thomas C Baghai1, Sven Hilbert6, Rainer Rupprecht1, Vladimir M Milenkovic1, Christian H Wetzel7.   

Abstract

The molecular pathomechanisms of major depressive disorder (MDD) are still not completely understood. Here, we follow the hypothesis, that mitochondria dysfunction which is inevitably associated with bioenergetic disbalance is a risk factor that contributes to the susceptibility of an individual to develop MDD. Thus, we investigated molecular mechanisms related to mitochondrial function in induced neuronal progenitor cells (NPCs) which were reprogrammed from fibroblasts of eight MDD patients and eight non-depressed controls. We found significantly lower maximal respiration rates, altered cytosolic basal calcium levels, and smaller soma size in NPCs derived from MDD patients. These findings are partially consistent with our earlier observations in MDD patient-derived fibroblasts. Furthermore, we differentiated MDD and control NPCs into iPS-neurons and analyzed their passive biophysical and active electrophysiological properties to investigate whether neuronal function can be related to altered mitochondrial activity and bioenergetics. Interestingly, MDD patient-derived iPS-neurons showed significantly lower membrane capacitance, a less hyperpolarized membrane potential, increased Na+ current density and increased spontaneous electrical activity. Our findings indicate that functional differences evident in fibroblasts derived from MDD patients are partially present after reprogramming to induced-NPCs, could relate to altered function of iPS-neurons and thus might be associated with the aetiology of major depressive disorder.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35732695     DOI: 10.1038/s41380-022-01660-1

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  49 in total

Review 1.  Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders.

Authors:  Ann Gardner; Richard G Boles
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-08-05       Impact factor: 5.067

2.  Pathophysiology of depression: do we have any solid evidence of interest to clinicians?

Authors:  Gregor Hasler
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

3.  Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients.

Authors:  Ann Gardner; Anna Johansson; Rolf Wibom; Inger Nennesmo; Ulrika von Döbeln; Lars Hagenfeldt; Tore Hällström
Journal:  J Affect Disord       Date:  2003-09       Impact factor: 4.839

Review 4.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

Review 5.  Impaired mitochondrial function in psychiatric disorders.

Authors:  Husseini Manji; Tadafumi Kato; Nicholas A Di Prospero; Seth Ness; M Flint Beal; Michael Krams; Guang Chen
Journal:  Nat Rev Neurosci       Date:  2012-04-18       Impact factor: 34.870

Review 6.  Gene-environment interactions in major depressive disorder.

Authors:  Torsten Klengel; Elisabeth B Binder
Journal:  Can J Psychiatry       Date:  2013-02       Impact factor: 4.356

7.  Mitochondrial respiration in blood platelets of depressive patients.

Authors:  Jana Hroudová; Zdeněk Fišar; Eva Kitzlerová; Martina Zvěřová; Jiří Raboch
Journal:  Mitochondrion       Date:  2013-05-17       Impact factor: 4.160

Review 8.  The psychiatric manifestations of mitochondrial disorders: a case and review of the literature.

Authors:  Rebecca E Anglin; Sarah L Garside; Mark A Tarnopolsky; Michael F Mazurek; Patricia I Rosebush
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

9.  Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.

Authors:  K A Garbett; A Vereczkei; S Kálmán; L Wang; Ž Korade; R C Shelton; K Mirnics
Journal:  Transl Psychiatry       Date:  2015-03-10       Impact factor: 6.222

10.  Mitochondrial respiration in peripheral blood mononuclear cells correlates with depressive subsymptoms and severity of major depression.

Authors:  A Karabatsiakis; C Böck; J Salinas-Manrique; S Kolassa; E Calzia; D E Dietrich; I-T Kolassa
Journal:  Transl Psychiatry       Date:  2014-06-10       Impact factor: 6.222

View more
  1 in total

Review 1.  Molecular pathways of major depressive disorder converge on the synapse.

Authors:  Gabriel R Fries; Valeria A Saldana; Johannes Finnstein; Theo Rein
Journal:  Mol Psychiatry       Date:  2022-10-06       Impact factor: 13.437

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.